Trump’s drug pricing order puts Roche’s $50 billion U.S. investment plans at risk

fastcompany.com/91334701/trumps-drug-pricing-order-threatens-roches-50-billion-us-investment-plans

U.S. President Donald Trump’s executive order on drug pricing threatens Roche’s planned $50 billion investment in the United States, the company said on Wednesday.
Trump’s order, signed on Monday, directs drugmakers to lower prices of brand-name medicines to align with those in other…

This story appeared on fastcompany.com, 2025-05-14 21:30:00.
The Entire Business World on a Single Page. Free to Use →